Brought to you by 
Verily and Sanofi create diabetes-focused JV Onduo
27 Jan 2023
Executive Summary
Sanofi and Google's Verily Life Sciences created a joint venture Onduo, which will focus on developing integrated treatment and monitoring solutions for patient with diabetes.
Deal Industry
- Medical Devices
- Pharmaceuticals
-
Medical Devices
- Monitoring Equipment & Devices
-
In Vitro Diagnostics
- Glucose Testing
-
Digital Health
- Disease Management
Deal Status
- Final
Deal Type
-
Alliance
- Includes Equity
- Joint Venture
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Verily and Sanofi create diabetes-focused JV Onduo
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice